# Cempra Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cempra-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Chapel Hill, US
- Website: www.cempra.com
- Total disclosed funding: $78M
- Latest round: Series C (May 14, 2009)
- Investors on record: 5

## About

Established in 2006 and based in North Carolina, US, Cempra Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the development of antibiotics that targets drug-resistant bacterial infections.

## Funding rounds

- Series C, May 14, 2009, $46M — Intersouth Partners, Quaker Partners Management, Aisling Capital, Devon Park Bioventures, Teachers' Private Capital
- Series B, Nov 29, 2007, $10M — Intersouth Partners, Aisling Capital, Teachers' Private Capital
- Series A, Jul 3, 2007, $15M — Intersouth Partners, Aisling Capital
- Series A, Aug 16, 2006, $7.5M — Intersouth Partners, Aisling Capital

## Investors

- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series A, Series B, Series C
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series A, Series B, Series C
- Teachers' Private Capital — Series B, Series C
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series C
- Devon Park Bioventures (https://capitalatlas.ai/funds/devon-park-bioventures) — Series C